Neith Corporation (6236.TWO)
TWD 26.9
(0.0%)
TWD 26.9
(0.0%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 192.15 Million TWD | -16.04% |
| 2022 | 228.86 Million TWD | 198.17% |
| 2021 | 76.75 Million TWD | -8.41% |
| 2020 | 83.79 Million TWD | 0.0% |
| 2019 | - TWD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 179.9 Million TWD | -6.38% |
| 2024 Q2 | 170.66 Million TWD | -5.14% |
| 2023 Q3 | 198.89 Million TWD | -7.29% |
| 2023 FY | 192.15 Million TWD | -16.04% |
| 2023 Q1 | 221.3 Million TWD | 0.0% |
| 2023 Q2 | 214.52 Million TWD | -3.06% |
| 2023 Q4 | 192.15 Million TWD | -3.39% |
| 2022 Q4 | - TWD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| SYN-TECH Chem. & Pharm. Co., Ltd. | 2.9 Billion TWD | 93.376% |
| Level Biotechnology Inc. | 822.67 Million TWD | 76.643% |
| TaiMed Biologics Inc. | 3.89 Billion TWD | 95.065% |
| GlycoNex Incorporation | 1.55 Billion TWD | 87.625% |
| GeneReach Biotechnology Corp. | 1.17 Billion TWD | 83.662% |
| OBI Pharma, Inc. | 5.6 Billion TWD | 96.571% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 748.57 Million TWD | 74.331% |
| Genomics BioSci & Tech. Co.,Ltd. | 1.13 Billion TWD | 83.053% |
| Visgeneer Inc. | 397.17 Million TWD | 51.62% |
| Lumosa Therapeutics Co., Ltd. | 1.65 Billion TWD | 88.399% |
| Medigen Vaccine Biologics Corporation | 6.09 Billion TWD | 96.846% |
| TaiwanJ Pharmaceuticals Co., Ltd. | 73.55 Million TWD | -161.227% |
| Enimmune corporation | 604.82 Million TWD | 68.23% |
| TaiRx, Inc. | 833.74 Million TWD | 76.953% |
| CHO Pharma, Inc. | 3.08 Billion TWD | 93.773% |
| BioLASCO Taiwan Co., Ltd. | 573.13 Million TWD | 66.474% |
| Sunny Pharmtech Inc. | 1.71 Billion TWD | 88.778% |
| Ever Supreme Bio Technology Co., Ltd | 2.07 Billion TWD | 90.744% |
| Feng Chi Biotech Corp. | 301.03 Million TWD | 36.169% |
| Lukas Biomedical Inc. | 441.19 Million TWD | 56.447% |
| RBC Bioscience Corporation | 753.79 Million TWD | 74.508% |
| NaviFUS Corp. | 490.53 Million TWD | 60.828% |
| BRIM Biotechnology, Inc. | 1.77 Billion TWD | 89.197% |
| Shine-On BioMedical Co.,Ltd. | 1.15 Billion TWD | 83.431% |
| Great Novel Therapeutics Biotech & Medicals | 644.84 Million TWD | 70.202% |
| Sagittarius Life Science Corp | 664.72 Million TWD | 71.093% |
| Bio Preventive Medicine Corp. | 264.65 Million TWD | 27.395% |
| Advagene Biopharma Co., Ltd. | 147.93 Million TWD | -29.891% |
| BioGend Therapeutics Co., Ltd. | 1.05 Billion TWD | 81.708% |
| G&E Herbal Biotechnology Co., Ltd. | 883.09 Million TWD | 78.241% |
| Andros Pharmaceuticals Co.,Ltd | 529.14 Million TWD | 63.686% |
| Lin BioScience, Inc. | 3.59 Billion TWD | 94.658% |
| Anti-Microbial Savior BioteQ Co., Ltd | 128.04 Million TWD | -50.064% |
| AP Biosciences Inc | 890.75 Million TWD | 78.428% |
| Sunmax Biotechnology Co., Ltd. | 2.15 Billion TWD | 91.1% |
| Syngen Biotech Co.,Ltd. | 3.1 Billion TWD | 93.814% |
| EirGenix Inc. | 11.16 Billion TWD | 98.279% |
| Pharmosa Biopharm Inc. | 1.33 Billion TWD | 85.592% |
| Mycenax Biotech Inc. | 3.77 Billion TWD | 94.904% |
| SynCore Biotechnology Co.,Ltd | 378.36 Million TWD | 49.215% |
| Eusol Biotech Co.,Ltd. | 410.25 Million TWD | 53.163% |
| NeoCore Technology Co., Ltd. | 548.74 Million TWD | 64.983% |
| VBI | 452.1 Million TWD | 57.498% |
| BiOptic Inc. | 613.77 Million TWD | 68.693% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | 1.22 Billion TWD | 84.323% |
| Sinew Pharma Inc. | 1.36 Billion TWD | 85.906% |
| Greenyn Biotechnology Co., Ltd | 1.16 Billion TWD | 83.455% |
| Medigen Biotechnology Corp. | 8.52 Billion TWD | 97.747% |
| 3D Global Biotech Inc. | 324.14 Million TWD | 40.721% |
| Intech Biopharm Corporation | 2.71 Billion TWD | 92.912% |
| Oneness Biotech Co., Ltd. | 15.36 Billion TWD | 98.749% |
| TWi Biotechnology, Inc. | 396.85 Million TWD | 51.581% |
| TCI GENE Inc. | 1.16 Billion TWD | 83.519% |
| MegaPro Biomedical Co., Ltd | 294.58 Million TWD | 34.771% |
| Senhwa Biosciences, Inc. | 1.36 Billion TWD | 85.906% |
| Taiwan Bio Therapeutics Co., Ltd | 941.76 Million TWD | 79.596% |
| NatureWise Biotech & Medicals Corporation | 698.45 Million TWD | 72.489% |
| PharmaEngine, Inc. | 3.95 Billion TWD | 95.14% |
| Savior Lifetec Corporation | 3.82 Billion TWD | 94.973% |
| TaiGen Biopharmaceuticals Holdings Limited | 1.22 Billion TWD | 84.376% |
| Meribank Biotech Co., Ltd | 1.06 Billion TWD | 81.907% |
| Acepodia, Inc. | 6.81 Billion TWD | 97.182% |
| Caliway Biopharmaceuticals Co., Ltd. | 3.82 Billion TWD | 94.978% |